End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
about
Healthcare quality in systemic lupus erythematosus: using Donabedian’s conceptual framework to understand what we knowDisparities, race/ethnicity and access to pediatric kidney transplantationAn overview of disparities and interventions in pediatric kidney transplantation worldwideBiomarkers for childhood-onset systemic lupus erythematosusESRD from lupus nephritis in the United States, 1995-2010Increased risk of death in African American patients with end-stage renal disease secondary to lupus.Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus NephritisSystemic lupus erythematosus in children and adolescents.Relationship of cell-free urine MicroRNA with lupus nephritis in children.Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus RegistryIncidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus RegistryRacial and ethnic differences in pediatric access to preemptive kidney transplantation in the United StatesBiomarkers and updates on pediatrics lupus nephritis.International validation of a urinary biomarker panel for identification of active lupus nephritis in children.Sociodemographic and geographic predictors of quality of care in United States patients with end-stage renal disease due to lupus nephritis.Update on differences between childhood-onset and adult-onset systemic lupus erythematosus.Recent progress in the treatment of lupus nephritis.Urine biomarkers in juvenile-onset SLE nephritis.Use of biomarkers in the management of children with lupus.Pediatric lupus nephritis: more options, more chances?Predicting decline of kidney function in lupus nephritis using urine biomarkers.Advances in the care of children with lupus nephritis.Serious Infection Rates among Children with Systemic Lupus Erythematosus Enrolled in Medicaid.Clinicopathological findings and outcome of lupus nephritis in Tunisian children: a review of 43 patients.Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes.Treatable renal disease in children with silent lupus nephritis detected by baseline biopsy: association with serum C3 levels.Post-transplant immune complex nephritis in a patient with systemic lupus erythematosus associated with ANCA vasculitis.Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus.
P2860
Q24613829-0A645D88-5F68-4613-A834-6A0157081B53Q26824093-C303E299-57CE-4F00-B868-64E66F1E4B32Q26851550-C3BBC4B6-0FC5-4BED-9717-78C33F962695Q27007470-4DC75EBE-7273-4350-84D0-FA9610CE16B0Q35051164-6999385B-A6A8-4328-A46F-D4F220A99916Q35310917-3B2AE17B-2C11-4BA3-A875-E3D1ABDF7EE3Q35321704-4CDD8F52-E0FA-49F3-B01F-55A37411B629Q35890096-74D39957-220C-451D-B43F-9F06E4316554Q35947491-34E332D3-F9A6-4FC4-8622-164F75B30E4CQ36461674-67887AC5-14A2-4D15-9654-20D7B38384C4Q36517240-CB7BB4D4-1F48-4FA4-9920-9A486EFA4B7CQ36540787-57DD4A68-261F-49B2-B3DB-AF0168313DF4Q37149478-FD99B8F3-4013-4789-A0DF-866F1CE06F22Q37167062-0AA9A2C2-7846-496A-8706-E3069C5E41AAQ37547407-FC2FFC51-C643-4EFF-A5D6-CB11DF0F0A45Q37684471-501B5325-092C-466E-B756-2B2963D16E42Q37690103-E4763A36-2138-4C2E-85AB-55472EE5FFAEQ38010014-EAC70F23-8159-42C5-B87D-02D72DB4F2A4Q38010347-4FAC00D9-E71A-4D87-8893-9A7325D62D56Q38077151-62B3D3D3-A5B2-4660-9EB5-AAE07BBBF3EEQ38102946-8880F65C-BF29-49F4-9C52-21B1201E8968Q38908585-312912CD-211C-4648-BC75-401981C6AACFQ39010807-083BBEAF-4364-41A9-9E11-07F5F2A07330Q40325720-A4E01CCC-08E4-4E0B-BDAE-C43892C195D1Q41495240-3F60CF2C-26F6-4892-9255-8C1FB00BDB84Q46496211-C509C820-12CE-4827-90D4-7014A24DF36BQ47619092-EB35811A-0576-4A13-AF74-65BC98267307Q47876387-7198AE09-11F6-4D9B-A66A-738EE1200A68Q53694045-336B6DC8-E2F6-4B1B-ACB9-6078054AA98D
P2860
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
@ast
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
@en
type
label
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
@ast
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
@en
prefLabel
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
@ast
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
@en
P2093
P2860
P356
P1476
End-stage renal disease due to lupus nephritis among children in the US, 1995-2006.
@en
P2093
Daniel H Solomon
Graciela S Alarcón
Karen H Costenbader
Linda T Hiraki
Steven R Alexander
Tamara Shaykevich
Wolfgang C Winkelmayer
P2860
P304
P356
10.1002/ART.30350
P577
2011-07-01T00:00:00Z